Korro Bio, Inc.
KRRO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703647
In the last 90 days, Korro Bio, Inc. insiders filed 1 open-market purchase and 8 sales; 106 institutions reported holding it in 13F filings for Q2 2026, worth $190.1M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Korro Bio, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 43 | 41 | −2 |
| Shares | 5.01M | 4.83M | −183.5K (−3.7%) |
| Value | $2.52M | $1.67M | −$849.4K (−33.7%) |
New holders (4)
Institutions that held Korro Bio, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| GTS Securities LLC | 223,278 | $77.3K | 0.00% |
| Wealthsource Partners, LLC | 23,250 | $8.04K | 0.00% |
| StoneX Group Inc. | 14,504 | $5.02K | 0.00% |
| Rhumbline Advisers | 1,058 | $366 | 0.00% |
Sold out (6)
Institutions that held Korro Bio, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Simplex Trading, LLC | 81,430 | $40.0K |
| Marshall Wace, LLP | 68,089 | $34.0K |
| Bridgeway Capital Management, LLC | 50,700 | $25.5K |
| Belpointe Asset Management LLC | 9,575 | $4.82K |
| City State Bank | 1,000 | $1.00K |
| Orion Capital Management LLC | 1,000 | $503 |